<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Wall St. Cheat Sheet &#187; Accretive Health NEGOTIATES Renewal with Ascension and Four Equity Insights Not to Miss</title>
	<atom:link href="http://wallstcheatsheet.com/stocks/accretive-health-negotiates-renewal-with-ascension-and-four-equity-insights-not-to-miss.html/feed/" rel="self" type="application/rss+xml" />
	<link>http://wallstcheatsheet.com</link>
	<description>Financial Media for Trading, Investing, and Business</description>
	<lastBuildDate>Sat, 25 May 2013 01:38:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>Accretive Health NEGOTIATES Renewal with Ascension and Four Equity Insights Not to Miss</title>
		<link>http://wallstcheatsheet.com/stocks/accretive-health-negotiates-renewal-with-ascension-and-four-equity-insights-not-to-miss.html/</link>
		<comments>http://wallstcheatsheet.com/stocks/accretive-health-negotiates-renewal-with-ascension-and-four-equity-insights-not-to-miss.html/#comments</comments>
		<pubDate>Thu, 05 Jul 2012 15:37:54 +0000</pubDate>
		<dc:creator>Brooke Edge</dc:creator>
				<category><![CDATA[Accretive Health]]></category>
		<category><![CDATA[AOL]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Investing]]></category>
		<category><![CDATA[KVH Industries]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[RackSpace]]></category>
		<category><![CDATA[Stocks]]></category>
		<category><![CDATA[Sunesis Pharmaceuticals]]></category>
		<category><![CDATA[Trading]]></category>
<stock_tickers>
<ticker><![CDATA[NASDAQ:KVHI]]></ticker>
<ticker><![CDATA[NASDAQ:SNSS]]></ticker>
<ticker><![CDATA[NYSE:AH]]></ticker>
<ticker><![CDATA[NYSE:AOL]]></ticker>
<ticker><![CDATA[NYSE:RAX]]></ticker>
</stock_tickers>
		<guid isPermaLink="false">http://wallstcheatsheet.com/?p=231868</guid>
		<description><![CDATA[Here's what analysts had to say about these companies today...]]></description>
				<content:encoded><![CDATA[<p><strong>Rackspace Hosting, Inc</strong> (<a href="http://wallstcheatsheet.com/stock-research/company?qs=RAX" target="_blank">NYSE:RAX</a>) estimates were reduced by Goldman thanks to FX volatility and a possible slowdown prior to its OpenStack migration. Shares are rated Neutral with a $52 price target, down from $57.</p>
<p><strong>Don&#8217;t Miss:</strong> <a title="Permanent Link to Is This Apple’s SECRET iPad Mini Game Plan?" href="http://wallstcheatsheet.com/stocks/is-this-apples-secret-ipad-mini-game-plan.html/" rel="bookmark">Is This Apple’s SECRET iPad Mini Game Plan? </a></p>
<p><strong>Accretive Health, Inc.</strong> (<a href="http://wallstcheatsheet.com/stock-research/company?qs=AH" target="_blank">NYSE:AH</a>): Following Accretive&#8217;s hinting in an SEC filing that it has in the works a negotiation for a five-year renewal with its major customer Ascension, Oppenheimer thinks Ascension will renew with Accretive by the end of July. Oppenheimer stands by an Outperform rating on the stock.</p>
<p><strong>AOL, Inc.</strong> (<a href="http://wallstcheatsheet.com/stock-research/company?qs=AOL" target="_blank">NYSE:AOL</a>): Needham elevated its price target AOL due to expectations for more impressive earnings in both Q2 and FY12. Needham repeats its Buy rating on the stock.</p>
<p><strong>KVH Industries Inc.</strong> (<a href="http://wallstcheatsheet.com/stock-research/company?qs=KVHI" target="_blank">NASDAQ:KVHI</a>): The price target for shares of KVH got a boost from Needham thanks to the company&#8217;s TACNAV award and mini-VSAT broadband business product cycle. Needham holds to a Buy rating on shares.</p>
<p><strong>Sunesis Pharmaceuticals Inc.</strong> (<a href="http://wallstcheatsheet.com/stock-research/company?qs=SNSS" target="_blank">NASDAQ:SNSS</a>): Cowen sees Sunesis Pharmaceuticals with a favorable risk/reward going into its analysis of its crucial VALOR trial in relapsed/refractory AML. Cowen thinks the probable result will be to either proceed as is or extend the trial, both which would be seen as positive. Shares are rated Outperform.</p>
<p><strong>Investing Insights:</strong> <a title="Permanent Link to EARLY BUZZERS: Target and Macy’s Dip on Sales, Apple Gearing Up for iPad-Mini" href="http://wallstcheatsheet.com/stocks/early-buzzers-target-and-macys-dip-on-sales-apple-gearing-up-for-ipad-mini.html/" rel="bookmark">EARLY BUZZERS: Target and Macy’s Dip on Sales, Apple Gearing Up for iPad-Mini. </a></p>
<p><em>Want news like this in real-time so you can get an edge? <a href="http://wallstcheatsheet.com/pro/">Click here for Wall St. Cheat Sheet Pro.</a></em></p>
 Read the <a href="http://wallstcheatsheet.com/stocks/accretive-health-negotiates-renewal-with-ascension-and-four-equity-insights-not-to-miss.html/">original article</a> from Wall St. Cheat Sheet]]></content:encoded>
			<wfw:commentRss>http://wallstcheatsheet.com/stocks/accretive-health-negotiates-renewal-with-ascension-and-four-equity-insights-not-to-miss.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

